• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮血管内动脉瘤修复术的血管入路:系统评价。

Percutaneous access for endovascular aneurysm repair: a systematic review.

机构信息

St. George's Vascular Institute, London, UK.

出版信息

Eur J Vasc Endovasc Surg. 2010 Jun;39(6):676-82. doi: 10.1016/j.ejvs.2010.02.001. Epub 2010 Feb 24.

DOI:10.1016/j.ejvs.2010.02.001
PMID:20185341
Abstract

INTRODUCTION

Recent developments in aortic stent-graft technology have led to an increase in the use of wholly percutaneous endovascular aneurysm repair (P-EVAR). The literature was systematically reviewed to analyse the results of P-EVAR.

METHODS

A systematic review of P-EVAR was performed using Ovid-MEDLINE in-process and other nonindexed citations and Ovid-MEDLINE and EMBASE (January 1991-July 2009). Primary outcomes reviewed were success rate and loco-regional complications. Secondary outcomes included; operative time, hospital stay, time to ambulation, blood loss and cost. Prospective randomised and controlled nonrandomised studies were included as were case series (retrospective and prospective). Case reports, letters, review articles and non-English language articles were excluded.

RESULTS

Twenty-two papers were identified. These included randomised trials (n=1); prospective nonrandomised (n=10) and retrospective studies (n=11). P-EVAR was attempted in 1087 patients (1751 groins). Overall success rate of percutaneous arterial closure was 92% (90.1-93.9, 95% CI). Access related complication rate was 4.4% (3.5-5.3, 95% CI). Seven studies provided data on access related complications in open access cohorts (O-EVAR). In these studies, P-EVAR was associated with fewer access related complications (RR 0.47, 95% CI 0.28-0.78, p=0.004). P-EVAR was associated with reduced operative time.

CONCLUSION

P-EVAR appears safe and effective in selected patients. Local access related complications were low. Further work is required to identify the most suitable candidates for P-EVAR.

摘要

简介

主动脉支架移植物技术的最新进展使得完全经皮血管内动脉瘤修复术(P-EVAR)的应用有所增加。系统回顾了文献,以分析 P-EVAR 的结果。

方法

使用 Ovid-MEDLINE 在处理中及其他非索引引文和 Ovid-MEDLINE 和 EMBASE(1991 年 1 月至 2009 年 7 月)对 P-EVAR 进行了系统回顾。主要观察指标为成功率和局部并发症。次要结果包括手术时间、住院时间、下床时间、出血量和费用。包括前瞻性随机对照非随机研究和病例系列(回顾性和前瞻性)。病例报告、信件、综述文章和非英语语言文章被排除在外。

结果

确定了 22 篇论文。这些论文包括随机试验(n=1);前瞻性非随机(n=10)和回顾性研究(n=11)。在 1087 例患者(1751 例腹股沟)中尝试了 P-EVAR。经皮动脉闭合的总体成功率为 92%(90.1-93.9,95%CI)。血管通路相关并发症发生率为 4.4%(3.5-5.3,95%CI)。7 项研究提供了开放通路队列(O-EVAR)中与血管通路相关的并发症数据。在这些研究中,P-EVAR 与较少的血管通路相关并发症相关(RR 0.47,95%CI 0.28-0.78,p=0.004)。P-EVAR 与手术时间缩短有关。

结论

在选定的患者中,P-EVAR 似乎是安全有效的。局部血管通路相关并发症较低。需要进一步的工作来确定最适合 P-EVAR 的患者。

相似文献

1
Percutaneous access for endovascular aneurysm repair: a systematic review.经皮血管内动脉瘤修复术的血管入路:系统评价。
Eur J Vasc Endovasc Surg. 2010 Jun;39(6):676-82. doi: 10.1016/j.ejvs.2010.02.001. Epub 2010 Feb 24.
2
Totally percutaneous versus surgical cut-down femoral artery access for elective bifurcated abdominal endovascular aneurysm repair.经皮与外科切开股动脉入路在择期分叉腹主动脉血管内修复术中的比较。
Cochrane Database Syst Rev. 2023 Jan 11;1(1):CD010185. doi: 10.1002/14651858.CD010185.pub4.
3
Laparoscopic surgery for elective abdominal aortic aneurysm repair.择期腹主动脉瘤修复的腹腔镜手术
Cochrane Database Syst Rev. 2017 May 4;5(5):CD012302. doi: 10.1002/14651858.CD012302.pub2.
4
Systematic Review With Meta-Analysis of Endovascular Versus Open Repair of Abdominal Aortic Aneurysm Repair in the Young.青年腹主动脉瘤血管内修复与开放修复对比的系统评价及Meta分析
J Endovasc Ther. 2025 Apr;32(2):276-289. doi: 10.1177/15266028231179419. Epub 2023 Jun 22.
5
Totally percutaneous versus surgical cut-down femoral artery access for elective bifurcated abdominal endovascular aneurysm repair.经皮完全穿刺与手术切开股动脉入路用于择期分叉型腹主动脉瘤腔内修复术
Cochrane Database Syst Rev. 2017 Feb 21;2(2):CD010185. doi: 10.1002/14651858.CD010185.pub3.
6
Endovascular stents for abdominal aortic aneurysms: a systematic review and economic model.血管内支架治疗腹主动脉瘤:系统评价和经济模型。
Health Technol Assess. 2009 Oct;13(48):1-189, 215-318, iii. doi: 10.3310/hta13480.
7
Percutaneous access for endovascular aortic aneurysm repair: A systematic review and meta-analysis.经皮血管腔内主动脉瘤修复术的入路:一项系统评价和荟萃分析。
Vascular. 2016 Dec;24(6):638-648. doi: 10.1177/1708538116639201. Epub 2016 Mar 21.
8
The Safety of Device Registries for Endovascular Abdominal Aortic Aneurysm Repair: Systematic Review and Meta-regression.血管内腹主动脉瘤修复器械注册研究的安全性:系统评价和荟萃回归分析。
Eur J Vasc Endovasc Surg. 2018 Feb;55(2):177-183. doi: 10.1016/j.ejvs.2017.11.013. Epub 2017 Dec 26.
9
Morphological suitability for endovascular repair, non-intervention rates, and operative mortality in women and men assessed for intact abdominal aortic aneurysm repair: systematic reviews with meta-analysis.评估女性和男性腹主动脉瘤腔内修复术的形态学适合性、非介入率和手术死亡率:系统评价和荟萃分析。
Lancet. 2017 Jun 24;389(10088):2482-2491. doi: 10.1016/S0140-6736(17)30639-6. Epub 2017 Apr 25.
10
Systematic review of recent evidence for the safety and efficacy of elective endovascular repair in the management of infrarenal abdominal aortic aneurysm.对近期关于选择性血管内修复治疗肾下腹主动脉瘤安全性和有效性证据的系统评价。
Br J Surg. 2005 Aug;92(8):937-46. doi: 10.1002/bjs.5123.

引用本文的文献

1
Comparative analysis of vascular closure devices for neuroendovascular procedures using Perclose versus Angioseal.使用Perclose与Angioseal进行神经血管内介入手术的血管闭合装置的对比分析。
Heliyon. 2024 Oct 30;10(21):e39975. doi: 10.1016/j.heliyon.2024.e39975. eCollection 2024 Nov 15.
2
Letter to the Editor re: "Systematic review and meta-analysis comparing Manta device and Perclose device for closure of large bore arterial access." . 2024 Jan 8:11297298231222314.致编辑的信:关于“比较Manta装置和Perclose装置用于大口径动脉穿刺口闭合的系统评价和荟萃分析”。2024年1月8日:11297298231222314 。
J Vasc Access. 2025 May;26(3):1076-1078. doi: 10.1177/11297298241254255. Epub 2024 Jun 1.
3
The Safety and Effectiveness of the Prostar XL Closure Device Compared to Open Groin Cutdown for Endovascular Aneurysm Repair.
Prostar XL 封堵装置与开放腹股沟切开术治疗血管内动脉瘤修复的安全性和有效性比较。
Vasc Endovascular Surg. 2023 Nov;57(8):848-855. doi: 10.1177/15385744231180663. Epub 2023 Jun 5.
4
Totally percutaneous versus surgical cut-down femoral artery access for elective bifurcated abdominal endovascular aneurysm repair.经皮与外科切开股动脉入路在择期分叉腹主动脉血管内修复术中的比较。
Cochrane Database Syst Rev. 2023 Jan 11;1(1):CD010185. doi: 10.1002/14651858.CD010185.pub4.
5
Case presentation of delayed superficial femoral artery pseudoaneurysm causing an acute deep vein thrombosis.股浅动脉假性动脉瘤延迟引发急性深静脉血栓形成的病例报告
J Vasc Surg Cases Innov Tech. 2022 Jul 2;8(3):404-407. doi: 10.1016/j.jvscit.2022.05.012. eCollection 2022 Sep.
6
Successful Percutaneous Fogarty Thrombectomy for Subacute Lower Limb Ischemia Due to Resistant Thrombus in the Popliteal Artery.经皮 Fogarty 血栓切除术治疗腘动脉内抵抗性血栓导致的亚急性下肢缺血获得成功。
Am J Case Rep. 2022 Jun 28;23:e936377. doi: 10.12659/AJCR.936377.
7
Comparison of percutaneous access and open femoral cutdown in elective endovascular aortic repair of abdominal aortic aneurysms.腹主动脉瘤择期血管腔内修复术中经皮入路与开放股动脉切开术的比较。
Turk Gogus Kalp Damar Cerrahisi Derg. 2022 Jan 28;30(1):11-17. doi: 10.5606/tgkdc.dergisi.2022.21898. eCollection 2022 Jan.
8
Comparison of Success Rate and Complications of Totally Percutaneous Decannulation in Patients With Veno-Arterial Extracorporeal Membrane Oxygenation and Endovascular Aneurysm Repair.静脉-动脉体外膜肺氧合和血管内动脉瘤修复患者完全经皮拔管成功率及并发症的比较
Front Med (Lausanne). 2021 Aug 20;8:724427. doi: 10.3389/fmed.2021.724427. eCollection 2021.
9
A Novel Plug-Based Vascular Closure Device for Percutaneous Femoral Artery Closure in Patients Undergoing Minimally-Invasive Valve Surgery.一种用于微创瓣膜手术患者经皮股动脉闭合的新型基于封堵器的血管闭合装置。
Front Cardiovasc Med. 2021 Jul 21;8:682321. doi: 10.3389/fcvm.2021.682321. eCollection 2021.
10
Initial experience with polymer endovascular aneurysm repair using the Alto stent graft.使用阿尔托覆膜支架进行聚合物血管内动脉瘤修复的初步经验。
J Vasc Surg Cases Innov Tech. 2020 Feb 1;6(1):6-11. doi: 10.1016/j.jvscit.2019.04.007. eCollection 2020 Mar.